Agios Pharmaceuticals Inc. logo

Agios Pharmaceuticals Inc.

AGIO | NASDAQ
Chart Builder DCF Calculator
$33.95
+$0.88 (+2.66%)
At close: Sep 21, 2026, 4:00 PM ET
$33.96
+$0.01 (+0.03%)
Pre-market: Sep 22, 2026, 8:33 AM ET

Market Data

Market Cap
$2.03B
Enterprise Value
$1.44B
Beta
0.60
Average Volume
1.08M
Shares Outstanding (Diluted)
59.49M
Shares Change YoY
2.69%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US00847X1046

Price Performance

Price Change 1M
2.1%
Price Change 3M
-4.6%
Price Change 6M
14.7%
Price Change YTD
24.9%
Price Change 1Y
-11.1%
Price Change 3Y
38.4%
Price Change 5Y
-28.6%
1M CAGR (ann.)
5.2%
1Y CAGR (ann.)
-10.5%
5Y CAGR (ann.)
-5.8%
All-Time CAGR
0.6%

Valuation

PE Ratio
-4.84
Forward PE
N/A
PEG Ratio
0.03
Forward PEG
0.14
PS Ratio
20.61
Forward PS
5.80
PB Ratio
1.98
P/FCF Ratio
-5.55
P/Adj. FCF Ratio
-4.79
P/OCF Ratio
-5.60
EV/Sales
14.65
EV/EBIT
-3.41
EV/EBITDA
-3.46
EV/FCF
-3.94
Earnings Yield
-20.6%
FCF Yield
-18.0%
Adj. FCF Yield
-20.9%

Financial Health

Net Cash
$617.58M
Total Debt
$31.17M
Cash & Short-Term Investments
$617.58M
Total Assets
$1.11B
Current Ratio
10.22
Quick Ratio
9.79
Debt / Equity Ratio
0.03
Debt / EBITDA
-0.07
Debt / FCF
-0.09
OCF / Debt
-11.57
Interest Coverage
0.00
Altman Z-Score
13.33
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
87.9%
Operating Profit Margin
-466.8%
EBITDA Margin
-423.8%
Net Profit Margin
-418.2%
FCF Margin
-371.4%
Adj. FCF Margin
-430.4%
SBC / Revenue
59.0%
SBC Impact (per share)
-15.9%

Returns

Return on Assets
-37.1%
Return on Equity
-35.7%
Return on Invested Capital
-43.3%
Return on Capital Employed
-44.2%
Return on Tangible Assets
-37.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
69.6%
Revenue CAGR 5Y
4.5%
Revenue CAGR 10Y
7.0%
EPS CAGR 3Y
-31.1%
EPS CAGR 5Y
55.8%
EPS CAGR 10Y
19.1%
FCF CAGR 3Y
-8.0%
FCF CAGR 5Y
-4.0%
FCF CAGR 10Y
-2.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
29
EPS Growth Next 3Y
31.5%
Revenue Growth Next 3Y
88.0%
Earnings Date
Oct 28, 2026
EPS Estimate (next Q)
-$1.21
EPS Growth Est (next Q)
-31.8%
Revenue Est (next Q)
$53.8M
Revenue Growth Est (next Q)
317.7%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$42.67
Price Target Upside
25.7%

Cash Flow

Operating Cash Flow
$-360.6M
Free Cash Flow
$-365.25M
Adj. Free Cash Flow
$-423.24M
FCF Per Share
-$6.14
OCF Per Share
-$6.06
OCF/S Ratio
-366.7%

Income Statement

Revenue
$98.34M
Gross Profit
$86.46M
Operating Income
$-459.02M
EBITDA
$-416.8M
Net Income
$-411.29M
EPS (Diluted)
-$7.01
Revenue / Employee
$182.11K
Profit / Employee
$-761.64K
Employees
540

© 2026 bestshares.com. All rights reserved.